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Glucose absorption during continuous ambulatory peritoneal
dialysis. Patients undergoing Continuous ambulatory peritoneal
dialysis (CAPD) are exposed to a continuous infusion of glucose
via their peritoneal cavity. We performed studies to quantitate
the amount of energy derived from dialysate glucose. Net
glucose absorption averaged 182 (SD) 61 g/day in 19 studies
with a dialysate dextrose concentration of 1.5 or 4.25 g/dl. The
amount of glucose absorbed per liter of dialysate (y) varied with
the concentration of glucose in dialysate (x), (y = II .3x — 10.9, r
0.96). The amount of glucose absorbed per day during a given
dialysis regimen was constant. Energy intake from dialysate
glucose was 8.4 2.8 kcal/kg of body wt per day, or 12 to 34% of
total energy intake. This additional energy may contribute to the
anabolic effect reported during CAPD. The ability to vary
glucose absorption by altering the dialysate glucose concentra-
tion may prove a useful tool to modify energy intake.
Absorption de glucose au cours de Ia diatyse péritonéale continue
ambulatoire. Les malades soumis a La dialyse peritoneale contin-
ue ambulatoire (CAPD) sont exposés a une administration con-
tinue de glucose via leur cavité péritonëale. La quantité d'éner-
gie qui derive du glucose du dialysat a été quantifiee. L'absorp-
tion nette de glucose est en moyenne de 182 (SD) 61 g/jour au
cours de 19 etudes avec un dialysat contenant du dextrose, 1,5
ou 4,25 g/dl. La quantité de glucose absorbée par litre de dialysat
(y) vane avec Ia concentration de glucose dans le dialysat (x), (y
= 1l,3x — 10,9, r = 0.96). La quantitC de glucose absorbée parjour pour un type donné de dialyse a été constante. L'entrée
d'energie a partir du glucose du dialysat était de 8,4 2,8 kcal/
kg de poids par jour, soit 12 a 34% de l'entrée totale d'énergie.
Cette energie supplémentaire peut contribuer a I'effet anabolique
rapporte au cours de CAPD. La possibilité de faire varier
l'absorption de glucose en modifiant Ia concentration de glucose
dans Ic dialysat peut étre un moyen utile pour influencer l'entrée
d'energie.
Patients undergoing intermittent peritoneal dialy-
sis absorb large quantities of glucose [1—4]; but, the
relatively short duration of each treatment limits the
nutritional significance of glucose absorption from
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dialysate. Continuous ambulatory peritoneal dialy-
sis (CAPD) is a new and increasingly used form of
maintenance dialysis therapy [5—9]. With CAPD,
dialysis is performed 24 hours a day, 7 days a week;
and thus, glucose absorption during dialysis may
provide a valuable source of energy to uremic
patients who are often undernourished. Despite the
potential value of glucose absorption during CAPD,
there is surprisingly little information about the
quantities of glucose absorbed. DeSanto el al stud-
ied glucose absorption in four patients undergoing
CAPD [101. Each was studied for one day with the
same quantities of dextrose in dialysate.
We, therefore, measured glucose absorption in
seven patients treated with CAPD in whom the
glucose concentration of the dialysate was varied.
The results indicate that substantial quantities of
glucose are absorbed during CAPD (182 [SD] 61
g/day), and this represents a major fraction of total
energy intake. The quantity absorbed was directly
correlated with the amount of glucose in the dialy-
sate and was quite constant for any given dialysis
regimen.
Methods
Nineteen studies of 4 to 21 days' duration were
carried out in seven clinically stable, chronically
uremic men undergoing CAPD. During each study,
the patients had fixed CAPD regimens, with the
number and duration of exchanges and the glucose
concentration in dialysate kept constant. The pa-
tients' ages ranged from 27 to 59 years, and body
weight varied from 71.3 to 89.8 kg (mean, 79.1 kg).
The seven patients had undergone intermittent pen-
toneal dialysis and/or CAPD for 6 to 50 months
prior to the study. During the study, patients lived
in either the Special Diagnostic and Treatment Unit
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at VA Wadsworth Medical Center or the Clinical
Research Center at UCLA Center for the Health
Sciences (CHS). They ingested constant diets pro-
viding either 1.0 0.11 or 1.4 0.08 g of protein
per kg of body wt per day and 32.9 3.5 kcal/kg of
body wt per day.
Three to five 2-liter bags of commercially avail-
able dialysate solution were instilled each day into
the peritoneal cavity by the method of Oreopoulos
et al [111. The number of exchanges was adjusted in
each patient to obtain a total urea clearance, calcu-
lated from the sum of dialysate urea plus urinary
urea, of 11 liters/day. As shown in Table 1, two
studies were performed with 3 exchanges/day, six
studies with 4 exchanges/day, and 11 studies with 5
exchanges/day. The number of exchanges contain-
ing either 1.5 g/dl or 4.25 g/dl of dextrose was
prescribed according to the need for fluid removal
in each patient.
Blood for glucose analysis was drawn into sodi-
um fluoride tubes every other morning before
breakfast. Glucose determinations were made in
both the inflow dialysate and in a pool of the daily
effluent dialysate. Serum and dialysate glucose con-
centrations were measured enzymatically with a
glucose analyzer (Beckman). The glucose concen-
trations of the commercial dialysate (Travenol Lab-
oratories, Deerfield, Illinois) measured repeatedly
in different lots, were 1.30 0.11 g/dl(N = 12) for
the 1.5% dialysate and 3.76 0.12 g/dl(N = 12) for
the 4.25% dialysate. Accuracy of analysis was
confirmed by recovery studies, which accounted
for 100.9 7.8% of glucose, added to dialysate in
concentrations of 1.0 and 4.0 g/dl.
With each exchange, the inflow and outflow
dialysate bags were weighed, and volumes were
calculated from the weight and the specific gravity
of the solutions. The measured volumes in 2-liter
inflow bags were 2.05 0.008 liters for 1.5%
dialysate and 2.06 0.012 liters for the 4.25%
solution. Daily glucose absorption was calculated
as the difference between the quantity of glucose
instilled into the peritoneal cavity and the amount
drained each day. The average concentration of
glucose (expressed in grams per deciliter) in infused
dialyste for each day is defined as the total quantity
of glucose divided by the total volume infused. For
calculation of the energy derived from dialysate, the
formula, 3.7 kcal/g glucose absorbed, was used [121.
All procedures were approved by the Committee on
Human Experimentation at VA Wadsworth and
UCLA, CHS and informed written consent was
obtained from each patient.
Results
In the 19 studies, the amount of glucose present
in the inflow dialysate averaged 252 62 g and
varied from 185 to 395 g/day (Table 1). An average
of 182 61 g of glucose was absorbed each day. In
each patient, the amount of glucose absorbed per
day on any given dialysis regimen was quite con-
stant; the average coefficient of variation was 4.9%
(range, 1.8 to 11.9%). Also, glucose absorption was
quite predictable on any particular regimen. (Fig.
1).
The quantity of glucose absorbed each day (y)
was highly correlated with the amount of glucose
instilled (x) with (y) (g/day) = 0.89x (g/day) — 43, r
= 0.91, N = 19. The amount of glucose absorbed
(in grams per liter of infused dialysate) correlated
closely with the average concentration of glucose in
dialysate (in grams per deciliter per day) (r = 0.96)
(Fig. 2). The energy intake from dialysate glucose
absorption varied from 4.6 to 14.4 kcal/kg of body
wt per day and averaged 8.4 2.7 kcal/kg of body
wt per day. In comparison, energy intake from food
averaged 2755 120 kcal/day (27.9 to 36.8 kcal/kg
of body wt per day). Thus, the glucose absorbed
from dialysate accounted for 20.3% (range, 12 to
34%) of total energy intake. The serum glucose
concentration in each patient varied from 88 to 144
mg/dl and was correlated weakly with glucose ab-
sorbed, r = 0.62, P < 0.01.
Discussion
The data from the present study demonstrate that
large quantities of glucose are absorbed from the
peritoneal cavity during CAPD. The quantity of
glucose absorbed contributed considerably to total
energy intake even though in the present study
dietary calorie intake was quite high. Most dialysis
patients ingest much less than 2700 kcal/day [13,
14], and thus dialysate glucose could constitute a
considerably greater fraction of their total energy
intake. Patients undergoing CAPD who ingest high-
protein intakes (1.4 g of protein/kg of body wt per
day) may be markedly anabolic (151, and such
positive nitrogen balances could be related to their
high total energy intake. Because wasting and mal-
nutrition occur commonly in chronic renal failure
[13, 141, the added glucose calories from CAPD
may be beneficial. But the absorption of large
quantities of glucose may contribute to hypertrigly-
ceridemia and obesity, which have been reported in
patients undergoing CAPD [8]. If hypertriglyceride-
mia and obesity were to develop, these complica-
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Table 1. Glucose absorption and energy intake during continuous ambulatory peritoneal dialysisa
11 5 252 62 182 61 113 19.8 32.9 3.5 8.4 2.7 41.3 3.5
a Allvalues are mean so. Patients 1, 2,4,6 and 7 were anuric; residual GFR in patients 3 and 5 was 1.0 and 3.0 mI/mm, respectively.
b Actual measured glucose concentrations were 1.30 and 3.76 g/dl.
C Diets varied slightly in separate studies performed at UCLA and VA Wadsworth.
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Fig. 1. Total glucose absorbed (giday S.D.) according to the
total number of exchanges and the number of exchanges with
1.5% or 4.25% glucose-containing dialysate. N is the total
number of study days.
tions might be treated by reducing carbohydrate
intake, as has been reported for patients undergoing
hemodialysis [16].
Because there is a high correlation between the
amount of glucose absorbed each day and the
average concentration of glucose in dialysate, the
net glucose uptake can be predicted from the con-
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Fig. 2. Glucose absorbed per liter of instilled dialysate (in grams
per liter) in relation to the average glucose concentration of the
dialysate used each day (in grams per deciliter per day). Each
circle represents a separate study; the solid line depicts the
regression analysis, y = 1i.3x — 10.9, r = 0.96, P < 0.001.
centration of glucose in the inflow. For example, a
CAPD patient performing 5 exchanges/day with two
2-liter exchanges of 1.5% dextrose (1.30 g/dl) and
three 2-liter exchanges of 4.25% dextrose (3.76 g/dl)
will have an average daily dialysate glucose concen-
tration of 2.80 g/dl. The quantity of glucose ab-
sorbed from each liter of inflow can be predicted
Glucose Glucose Energy intake
No. and type
Age bagb (1.5%!
Patient yr Study no. 4.25%)
Duration of study
days
inflow absorbed
giday
Serum
glucose
mg/dl
kcal/kg of body wt per day
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1 59 1 2/2 7 211 180 2.6 114 6.9 27.9 8.9 36.8
2 1/3 14 264 218 3.7 126 10.7 27.9 10.8 38.7
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from the equation, y = 11.3x — 10.9 (Fig. 2), as
follows:
Glucose absorbed = 11.3 (2.8) — 10.9 = 20.7 g
of glucose/liter of dialysate inflow
or 20.7 g/liter x 10 liters of inflow = 207 g/day
DeSanto et a! reported that in four patients, each
receiving an average daily glucose concentration of
2.6 g/dl, glucose absorption averaged 217 4.7 g/
day (range, 214 to 224) 10]. This is similar to the
quantity that would be predicted from our equation.
It is also noteworthy that, as in the present study,
the coefficient of variation for glucose absorption
from their four patient studies was low, 2.2%. This
finding supports the conclusion that the quantity of
net glucose absorption during CAPD can be accu-
rately predicted.
The ability to vary the quantity of net glucose
absorbed by altering the dialysate glucose concen-
trations may prove useful. In a malnourished pa-
tient, it may be advisable to increase the number of
hypertonic exchanges to increase his energy intake.
Such a patient could increase dietary fluid and salt
intake so that he can receive an increased number
of 4.25% dialysate exchanges. On the other hand, a
patient with obesity and/or an elevated triglyceride
level could restrict his fluid intake and use fewer
hypertonic exchanges, with a reduction in dialysate
glucose absorption. Thus, the critical dependence
of dialysate glucose absorption on dialysate glucose
concentration may allow the clinician to modify the
energy intake, depending on the patient's nutrition-
al status and the limits imposed by his need for
ultrafiltration and fluid removal.
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